Prognostic role of CHEK2, FASN and Her2/neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC).

MLA

Elaidy, Noha F., et al. “Prognostic Role of CHEK2, FASN and Her2/Neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC).” Egyptian Journal of Hospital Medicine, vol. 91, Apr. 2023, pp. 5266–75. EBSCOhost, https://doi.org/10.21608/ejhm.2023.305065.

APA

Elaidy, N. F., Abdelbary, A. M., Qasem, E. R., Eliwa, A. M., & Ibrahim, H. M. (2023). Prognostic role of CHEK2, FASN and Her2/neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC). Egyptian Journal of Hospital Medicine, 91, 5266–5275. https://doi.org/10.21608/ejhm.2023.305065

Chicago

Elaidy, Noha F., Abeer M. Abdelbary, Ebtisam R. Qasem, Ahmed M. Eliwa, and Hanaa M. Ibrahim. 2023. “Prognostic Role of CHEK2, FASN and Her2/Neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC).” Egyptian Journal of Hospital Medicine 91 (April): 5266–75. doi:10.21608/ejhm.2023.305065.